000 | 02202 a2200565 4500 | ||
---|---|---|---|
005 | 20250515154024.0 | ||
264 | 0 | _c20090309 | |
008 | 200903s 0 0 eng d | ||
022 | _a1940-6215 | ||
024 | 7 |
_a10.1158/1940-6207.CAPR-08-0021 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBrown, Powel H | |
245 | 0 | 0 |
_aCombination chemoprevention of HER2/neu-induced breast cancer using a cyclooxygenase-2 inhibitor and a retinoid X receptor-selective retinoid. _h[electronic resource] |
260 |
_bCancer prevention research (Philadelphia, Pa.) _cAug 2008 |
||
300 |
_a208-14 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
650 | 0 | 4 | _aBexarotene |
650 | 0 | 4 |
_aCarcinoma _xgenetics |
650 | 0 | 4 | _aCelecoxib |
650 | 0 | 4 |
_aCell Transformation, Neoplastic _xdrug effects |
650 | 0 | 4 |
_aChemoprevention _xmethods |
650 | 0 | 4 |
_aCyclooxygenase 2 Inhibitors _xadministration & dosage |
650 | 0 | 4 | _aDrug Evaluation, Preclinical |
650 | 0 | 4 |
_aEicosanoids _xmetabolism |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGenes, erbB-2 _xphysiology |
650 | 0 | 4 |
_aMammary Neoplasms, Experimental _xgenetics |
650 | 0 | 4 |
_aMammary Tumor Virus, Mouse _xgenetics |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Transgenic |
650 | 0 | 4 |
_aPyrazoles _xadministration & dosage |
650 | 0 | 4 |
_aRetinoid X Receptors _xagonists |
650 | 0 | 4 |
_aRetinoids _xadministration & dosage |
650 | 0 | 4 |
_aSubstrate Specificity _xdrug effects |
650 | 0 | 4 |
_aSulfonamides _xadministration & dosage |
650 | 0 | 4 |
_aTetrahydronaphthalenes _xadministration & dosage |
700 | 1 | _aSubbaramaiah, Kotha | |
700 | 1 | _aSalmon, Amoi P | |
700 | 1 | _aBaker, Rebecca | |
700 | 1 | _aNewman, Robert A | |
700 | 1 | _aYang, Peiying | |
700 | 1 | _aZhou, Xi Kathy | |
700 | 1 | _aBissonnette, Reid P | |
700 | 1 | _aDannenberg, Andrew J | |
700 | 1 | _aHowe, Louise R | |
773 | 0 |
_tCancer prevention research (Philadelphia, Pa.) _gvol. 1 _gno. 3 _gp. 208-14 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1158/1940-6207.CAPR-08-0021 _zAvailable from publisher's website |
999 |
_c18587085 _d18587085 |